Alx Oncology Holdings (ALXO) Operating Income Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - | 40.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.40% |
| Dec 31, 2025 | 24.80% |
| Sep 30, 2025 | 30.81% |
| Jun 30, 2025 | 35.83% |
| Mar 31, 2025 | 15.74% |
| Dec 31, 2024 | -134.60% |
| Sep 30, 2024 | 38.87% |
| Jun 30, 2024 | -12.91% |
| Mar 31, 2024 | -17.26% |
| Dec 31, 2023 | 374.64% |
| Sep 30, 2023 | -45.24% |
| Jun 30, 2023 | -8.84% |
| Mar 31, 2023 | -30.13% |
| Dec 31, 2022 | -13.16% |
| Sep 30, 2022 | -49.26% |
| Jun 30, 2022 | -107.31% |
| Mar 31, 2022 | -74.18% |
| Dec 31, 2021 | -274.86% |
| Sep 30, 2021 | -150.55% |
| Jun 30, 2021 | -51.10% |
| Mar 31, 2021 | -171.04% |
| Dec 31, 2020 | 310.57% |
| Sep 30, 2020 | -223.30% |
| Jun 30, 2020 | -157.51% |